Yali Cao
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
-
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- Histone Deacetylase Inhibitors Research
- RNA modifications and cancer
Papers in
-
- Circular RNAs in diseases 7
- Histone Deacetylase Inhibitors Research 3
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 5
- Breast Cancer Treatment Studies 4
- Co-authors
- Xiaobo Wu (6 shared papers)Rui Wang (2 shared papers)Jianguo Shao (3 shared papers)Jingxian Ding (6 shared papers)Qiuming Liu (4 shared papers)Ningning Yan (3 shared papers)Liang Xu (4 shared papers)Xiaochun Fei (1 shared paper)
- Journals
- OncoTargets and Therapy (3 papers)Frontiers in Oncology (2 papers)World Journal of Gastroenterology (2 papers)Tumor Biology (2 papers)Medicine (1 paper)
- Partner nations
- ChinaHong KongSwitzerland
In The Last Decade
Yali Cao
36 papers receiving 634 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 207
- Molecular Biology 297
- Oncology 93
- Hepatology 22
- Geriatrics and Gerontology 7
Countries citing papers authored by Yali Cao
This map shows the geographic impact of Yali Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Cao more than expected).
Fields of papers citing papers by Yali Cao
This network shows the impact of papers produced by Yali Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Cao. The network helps show where Yali Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Yali Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 72 | |
| 2 | 2017 | 71 | |
| 3 | 2014 | 66 | |
| 4 | 2015 | 47 | |
| 5 | 2017 | 45 | |
| 6 | 2018 | 40 | |
| 7 | 2016 | 36 | |
| 8 | 2019 | 35 | |
| 9 | 2013 | 34 | |
| 10 | 2017 | 32 | |
| 11 | 2023 | 14 | |
| 12 | 2018 | 14 | |
| 13 | 2019 | 14 | |
| 14 | 2020 | 14 | |
| 15 | 2007 | 12 | |
| 16 | 2023 | 10 | |
| 17 | 2013 | 10 | |
| 18 | 2023 | 9 | |
| 19 | 2022 | 8 | |
| 20 | 2010 | 7 |
About Yali Cao
Yali Cao is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 646 indexed citations. Recurring topics across this work include Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (5 papers), Breast Cancer Treatment Studies (4 papers), Advanced Breast Cancer Therapies (3 papers), Breast Lesions and Carcinomas (3 papers), Cancer Mechanisms and Therapy (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Cancer Research (207 citations), Molecular Biology (297 citations), Oncology (93 citations), Hepatology (22 citations) and Geriatrics and Gerontology (7 citations). Yali Cao has collaborated with scholars based in China, Hong Kong and Switzerland. Frequent co-authors include Xiaobo Wu, Rui Wang, Jianguo Shao, Jingxian Ding, Qiuming Liu, Ningning Yan, Liang Xu, Xiaochun Fei, Jianhong Tu and Le Zhang. Their work appears in journals such as OncoTargets and Therapy, Frontiers in Oncology, World Journal of Gastroenterology, Tumor Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.